IVERIC bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.
| Website | http://www.ivericbio.com |
| Ticker | ISEE |
| Revenue | $19.9 million |
| Funding | $316 million |
| Employees | View employees |
| Address | 8 Sylvan Way, Parsippany, New Jersey 07054, US |
| Phone | +1 609-474-6755 |
| Fax | (609) 452-7435 |
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Ocugen, Ocular Therapeutix, Inc., Kodiak Sciences, REGENXBIO Inc., Poseida Therapeutics, Inc., Catalyst Biosciences (view competitors) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular IVERIC bio employee's phone or email?
IVERIC bio Questions
The IVERIC bio annual revenue was $19.9 million in 2026.
IVERIC bio is based in Parsippany, New Jersey.
The NAICS codes for IVERIC bio are [325, 32].
The SIC codes for IVERIC bio are [283, 28].
G2Crowd Trusted
300K+
Plugin Users
